Pharma

The Readout Elaine Chen

STAT Plus: uniQure shares soar on Huntington’s data

Biotech Matthew Herper

STAT Plus: Mikael Dolsten, Pfizer CSO who could take on Covid but not Wall Street, to step down

The Readout Elaine Chen

STAT Plus: Lilly’s obesity drug looks more potent than Novo’s in observational study

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: We’re reading about an FTC report on PBMs, Lilly vs. Novo weight loss study, and more

Pharmalot Ed Silverman

STAT Plus: FTC report finds PBMs profit at the expense of patients and independent pharmacies

Politics Rachel Cohrs Zhang

STAT Plus: Drugmakers are losing crucial friends on Capitol Hill

Pharmalot Ed Silverman

STAT Plus: South Africa and J&J reach a deal to widen access to a key tuberculosis treatment

The Readout Meghana Keshavan

STAT Plus: The biotech news you missed this week

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: We’re reading about AbbVie spending on doctors, a new Lilly deal, and more

Pharmalot Ed Silverman

STAT Plus: Biden administration appeals jury finding in battle over patents for HIV prevention pills

Exclusive Nicholas Florko and J. Emory Parker

STAT Plus: AbbVie dramatically outspent its pharma company rivals in 2023 to promote its drugs to doctors

Politics Rachel Cohrs Zhang

STAT Plus: Judge rules against Boehringer Ingelheim in pharma’s latest legal loss on Medicare negotiation

Pharmalot Ed Silverman

STAT Plus: U.K. trade group scolds Novo, Novartis, Pfizer, and Otsuka for violating industry codes

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: We’re reading about Ozempic and an eye condition, a failed Roche cancer drug trial, and more

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: We’re reading about a GSK vaccine deal, an Alzheimer’s drug approval, and more

Pharma Adam Feuerstein

STAT Plus: GSK buys mRNA-based Covid, flu vaccines from CureVac in restructured partnership

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: We’re reading about FTC probing Teva patents, a Moderna flu vaccine contract, and more

Pharmalot Ed Silverman

STAT Plus: After months of warnings, FTC opens investigation into Teva over ‘improper’ patents

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: We’re reading about indicted drug wholesalers, a gene therapy rejection, and more

Pharma Nicholas Florko, Lizzy Lawrence, John Wilkerson, and Elaine Chen

STAT Plus: Supreme Court’s gutting of Chevron doctrine could mean headaches for drug industry

Pharmalot Ed Silverman

STAT Plus: Drug wholesaler owners indicted for alleged role in diverting Gilead and J&J HIV medicines

Pharmalot Ed Silverman

STAT Plus: Up and down the ladder: The latest comings and goings

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: We’re reading about the Purdue bankruptcy ruling, a Merck rejection, and more

The Readout Meghana Keshavan

STAT Plus: Will Medicare finally begin covering weight loss drugs like Zepbound and Wegovy?

Pharmalot Ed Silverman

Supreme Court rejects the controversial Purdue bankruptcy plan

The Readout Elaine Chen

STAT Plus: Exclusive: European VC Forbion hires Dyne CEO, expands in US

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: We’re reading about EMA plans for GLP-1 shortages, Walgreens store closings, and more

Biotech John Wilkerson

STAT Plus: FDA issues long-awaited draft guidance for enrolling more people of color in clinical trials

Politics Rachel Cohrs Zhang

STAT Plus: House panel proposes new strategy for Medicare to cover weight loss drugs Wegovy, Zepbound